Bladder cancer
Non-muscle-invasive Bladder Cancer (NMIBC)
| Compare your decisions with peers | |
| See expert recommendations | |
| Get the best available evidence |
What are these clinical cases about?
Urinary biomarker tests can detect bladder cancer recurrence and optimise clinical decision-making. Recent developments in medical diagnostics aim to significantly reduce the number and frequency of invasive procedures, alleviating the heavy burden for the patient and physician. At BCaMonitor, we want to offer you time-efficient and learner-centric ways of continuous medical education (CME) on urinary biomarkers for non-muscle invasive bladder cancer (NMIBC) surveillance. That’s why we have chosen for this case-based method of learning. The aim of these clinical cases is to share expert experiences that can support you in your daily clinical practice.
What is BCaMonitor.org about?
BCaMonitor.org serves as a comprehensive information resource for urologists and NMIBC patients about using biomarkers in the surveillance of NMIBC.
For more information and updates on biomarker tests for NMIBC: Get our peer-reviewed slide resource and brochure!
Interested in more uro-ocology cases?
If you want to receive independent clinical cases in urology and GU oncology, you can also join the PinPoint Case Platform!
• Receive essential clinical cases via email with targeted feedback
• Compare your decisions with peers and experts
• Get accredited CME courses for free